TCP1 encodes a molecular chaperone protein that modulates the PI3K/AKT/mTOR signaling pathway, thereby promoting ovarian cancer cell proliferation (Weng et al. 2021) and enhancing drug resistance in acute myeloid leukemia (Chen et al. 2021). This evidence concerns the gene MTOR and ovarian carcinoma.